ZELAMFI Trademark

Trademark Overview

On Friday, September 23, 2022, a trademark application was filed for ZELAMFI with the United States Patent and Trademark Office. The USPTO has given the ZELAMFI trademark a serial number of 97604580. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, September 11, 2024. This trademark is owned by Pfizer Inc.. The ZELAMFI trademark is filed in the Pharmaceutical Products category with the following description:

vaccines for human use
zelamfi

General Information

Serial Number97604580
Word MarkZELAMFI
Filing DateFriday, September 23, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, September 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 22, 2023

Trademark Statements

Goods and Servicesvaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 11, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192

Trademark Events

Event DateEvent Description
Tuesday, September 27, 2022NEW APPLICATION ENTERED
Tuesday, October 11, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 21, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, March 28, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 28, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 21, 2023TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Friday, July 7, 2023ASSIGNED TO EXAMINER
Friday, July 14, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 22, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, August 2, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 22, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 17, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 8, 2024SOU EXTENSION 1 GRANTED
Friday, March 8, 2024SOU TEAS EXTENSION RECEIVED
Friday, March 8, 2024SOU EXTENSION 1 FILED
Saturday, March 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 11, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 11, 2024SOU EXTENSION 2 GRANTED
Wednesday, September 11, 2024SOU EXTENSION 2 FILED

Related Keywords

zelamfi human vaccines